全文获取类型
收费全文 | 1465844篇 |
免费 | 167233篇 |
国内免费 | 70708篇 |
专业分类
耳鼻咽喉 | 11128篇 |
儿科学 | 15822篇 |
妇产科学 | 13511篇 |
基础医学 | 102841篇 |
口腔科学 | 31307篇 |
临床医学 | 183484篇 |
内科学 | 144167篇 |
皮肤病学 | 13458篇 |
神经病学 | 48627篇 |
特种医学 | 52431篇 |
外国民族医学 | 597篇 |
外科学 | 135235篇 |
综合类 | 339914篇 |
一般理论 | 41篇 |
预防医学 | 163006篇 |
眼科学 | 36048篇 |
药学 | 205837篇 |
2489篇 | |
中国医学 | 124572篇 |
肿瘤学 | 79270篇 |
出版年
2024年 | 1252篇 |
2023年 | 27389篇 |
2022年 | 52612篇 |
2021年 | 68566篇 |
2020年 | 71871篇 |
2019年 | 36641篇 |
2018年 | 37237篇 |
2017年 | 33352篇 |
2016年 | 32335篇 |
2015年 | 32563篇 |
2014年 | 137063篇 |
2013年 | 127014篇 |
2012年 | 189044篇 |
2011年 | 185163篇 |
2010年 | 130274篇 |
2009年 | 104144篇 |
2008年 | 78962篇 |
2007年 | 92104篇 |
2006年 | 72376篇 |
2005年 | 47692篇 |
2004年 | 39342篇 |
2003年 | 33068篇 |
2002年 | 24271篇 |
2001年 | 18111篇 |
2000年 | 12342篇 |
1999年 | 4831篇 |
1998年 | 2531篇 |
1997年 | 2030篇 |
1996年 | 1041篇 |
1995年 | 793篇 |
1994年 | 760篇 |
1993年 | 608篇 |
1992年 | 1486篇 |
1991年 | 1213篇 |
1990年 | 1053篇 |
1989年 | 867篇 |
1988年 | 531篇 |
1987年 | 301篇 |
1986年 | 103篇 |
1985年 | 150篇 |
1984年 | 149篇 |
1983年 | 73篇 |
1982年 | 70篇 |
1981年 | 44篇 |
1980年 | 32篇 |
1979年 | 20篇 |
1978年 | 19篇 |
1977年 | 17篇 |
1976年 | 23篇 |
1974年 | 15篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
王艳 《中国医学文摘.耳鼻咽喉科学》2021,(2):124-125,130
目的观察银杏叶提取物注射液治疗突发性耳聋的有效性及药理作用分析。方法选取我院自2019年1月~2020年6月收治的突发性耳聋患者80例,随机分为实验组和对照组,每组40例。两组均进行常规治疗和辅助治疗,对照组采取静脉滴注丹参注射液联合低分子右旋糖酐氨基酸注射液治疗,实验组采取静脉银杏叶提取物注射液联合低分子右旋糖酐氨基酸注射液治疗。比较两组患者临床治疗效果和不良反应发生情况。结果经过治疗发现,实验组有效率97.5%,显著高于对照组82.5%,差异具有统计学意义(P<0.05)。实验组出现恶心呕吐不良反应仅1例,不良反应发生率为2.5%;对照组出现4例恶心呕吐、2例乏力以及2例头晕,不良反应发生概率为20.0%。实验组不良反应发生概率显著低于对照组,具有统计学意义(P<0.05)。结论突发性耳聋采用银杏叶提取物注射液治疗对提高治疗有效率有显著效果,并且不良反应发生概率低,值得临床推广使用。 相似文献
2.
阻塞性睡眠呼吸暂停低通气综合症(obstructive sleep apnea hypopnea syndrome,OSAHS)是一种常见的睡眠障碍性疾病,长期的呼吸暂停和低通气可引起不同程度的低氧血症及高碳酸血症,继发组织缺氧,最终导致多器官功能损害,其中包括第8对颅神经-听神经的损害。临床观察中也发现了部分OSAHS患者出现了听力下降、耳鸣症状。本文在前人研究的基础上主要从四方面阐述OSAHS对听觉系统的损害:中耳压力的变化、胃食道反流对中耳的影响、缺氧对传导通路的损害、快速眼动时期(The rapid eye movement period,REM)剥夺引起微环境的改变。 相似文献
3.
目的探析中高频听力下降型突发性聋采取耳后注射甲强龙治疗的临床效果及可行性。方法选取2019年5月~2020年7月本院耳鼻喉科就诊的中高频听力下降型突发性聋患者,共纳入病例54例,以随机法分组,即常规组(n=27)和观察组(n=27),常规组予常规治疗,观察组采取耳后注射甲强龙,比较两组效果。结果观察组有效率相比于常规组显著提高(P<0.05);治疗3周后,观察组2000~8000Hz频率听力提高值与常规组比(P<0.05)。结论中高频听力下降型突发性聋采取耳后注射甲强龙治疗效果理想,值得推广。 相似文献
4.
Akira Ohkoshi Naoko Sato Koreyuki Kurosawa Hitoshi Miyashita Ryo Ishii Ayako Nakanome Takenori Ogawa Masahiro Tachi Tetsu Takahashi Yukio Katori 《Auris, nasus, larynx》2021,48(5):1007-1012
ObjectiveComputer-aided design and computer-aided manufacturing (CAD/CAM) techniques are increasingly applied to mandibular reconstruction, but the superiority of this method in oral food intake has not been well established. Considering the extent of mandibular defects, this retrospective study was aimed to clarify the impact of CAD/CAM mandibular reconstruction on chewing and swallowing function after surgery for locally advanced oral cancer.Materials and methodsWe performed a retrospective review of 50 patients who had undergone segmental mandibulectomy with free flap reconstruction for locally advanced oral cancer. The patients’ Functional Oral Intake Scale scores were measured at 3 months after surgery, and possible contributing factors including CAD/CAM mandibular reconstruction and the extent of mandibular defects for oral food intake were subjected to univariate analysis and multivariate logistic regression analysis.ResultsMultivariate logistic regression analysis showed that CAD/CAM mandibular reconstruction was independently associated with good oral intake, whereas both anterior or extensive mandibular resection and glossectomy were also independently associated with poor oral intake after surgery.ConclusionThe present study showed the positive impact of CAD/CAM mandibular reconstruction on chewing and swallowing function after surgery for locally advanced oral cancer for the first time. 相似文献
5.
目的探讨通过下食管括约肌(lower esophageal sphincter,LES)扩张建立咽喉反流性疾病(laryngophyngeal reflux disease,LPRD)模型的可行性。方法18只新西兰白兔随机分为实验组10只和对照组8只,对实验组动物进行LES测压定位后,使用球囊对LES进行注水扩张,对照组同法置入球囊,但不进行球囊注水。扩张前1周及扩张后2周行咽喉及食管下段pH监测,LES平均静息压检测;扩张前1周、扩张后2周及8周行喉镜检查,进行喉镜下反流体征评分;扩张后8周处死动物,对其喉部及食管下段黏膜取材,光镜下观察其病理变化。结果扩张后pH监测验证实验组造模成功8只(80.0%,8/10),实验组扩张前咽喉酸反流时间百分比(%)、反流事件数(次)、反流最长时间(s)分别为0(0,0)、0(0,0)、0(0,0),扩张后分别为17.5(8.2,29.4)、3(1,5.5)、17.2(10.2,30.8),较扩张前增加,差异有统计学意义(P<0.01)。实验组扩张前食管下段pH监测酸反流时间百分比、反流事件数、反流最长时间分别为0(0,0.7)、0(0,1)、0(0,1.2),扩张后分别为23.1(4.8,49.5)、3(1,6)、25.9(11.5,56.8),较扩张前增加,差异有统计学意义(P<0.01)。实验组扩张前LES压力28.0±5.6 mmHg,较扩张后(17.2±3.3 mmHg)升高,差异有统计学差异(P=0.001);实验组扩张前RFS评分3.1±1.2分,扩张后2周为3.6±1.4分,扩张后8周为8.6±2.5分,扩张前和扩张后2周差异无统计学意义(P=0.482),但扩张前与扩张后8周差异有统计学意义(P=0.005)。病理检查示实验组喉部及食管黏膜均可观察到不同程度慢性炎症。结论食管下括约肌球囊扩张可安全、有效地建立LPRD动物模型。 相似文献
6.
Shintaro Sueyoshi Hirohito Umeno Takashi Kurita Mioko Fukahori Shun-ichi Chitose 《Auris, nasus, larynx》2021,48(5):949-955
ObjectiveFibrotic changes in the vocal fold mucosa have been observed in patients with vocal fold scarring, aged vocal fold, and sulcus vocalis, which often lead to severe voice disorders. Previous research suggests that the basic fibroblast growth factor (b FGF) improves variations in vocal fold properties [1,2]. Although clinical studies on b FGF treatments have been conducted [3,4,5], these studies only demonstrated the efficacy of this drug over a short period. The present study is the first to investigate the long-term efficacy of b FGF treatment.Methodsb FGF injections were performed in six patients from January of 2016 to December of 2017 at our institution. Patient follow-up continued for at least two years after the last injection. Three patients had vocal fold scarring, two had aged vocal fold atrophy, and one patient had sulcus vocalis. Each vocal fold was injected with 10 µg of b FGF four times. Voice and stroboscopic examinations were performed after surgery (at one month, three months, six months, one year, two years). Fundamental frequency, maximum phonation time (MPT), mean flow rate (MFR), amplitude perturbation quotient (APQ), pitch perturbation quotient (PPQ), and noise-to-harmonic ratio (NHR), and voice handicap index-10 (VHI-10) were examined and compared statistically between the pretreatment time and at each posttreatment time point.ResultsThe speaking F0 had an obvious decreasing tendency, with significant differences suggesting the increase in volume in the vocal folds. Aerodynamic parameters also showed small improvements. The most remarkable improvement was observed in the acoustic parameters, indicating that the treatment could improve the vocal fold to make vibrations symmetrically and regularly for a long period. Achievement of symmetry and regularity on vocal fold vibrations suggested the property changes had happened in the vocal folds. Consequently, the score of VHI-10 had improved, indicating high patient satisfaction with this treatment.Conclusionb FGF injections could be a reliable treatment option for diseases that deteriorate the property of vocal fold. 相似文献
7.
目的探讨个性化健康教育对甲状腺癌手术患者留置针留置时间及相应并发症的影响。方法选取2019年3月至2020年5月间我院收治的甲状腺癌,且于我院行手术治疗的患者共80例,将其以数字随机表法的分组形式平均分为观察组及对照组,每组40例。给予对照组患者常规护理措施,于此基础上给予观察组患者个性化健康教育护理,对比两组患者静脉留置针留置时间及相应并发症产生情况。结果观察组患者留置针留置时间明显长于对照组患者,差异具有统计学意义(P<0.05);观察组患者不良反应发生几率明显低于对照组患者,差异具有统计学意义(P<0.05)。结论在甲状腺癌术后患者护理中使用个性化健康教育护理模式可有效延长留置针留置时间,减少并发症产生,给临床治疗带来极大便利,值得于临床中进一步推广使用。 相似文献
8.
目的 通过4DCT(four-dimensional CT)动态评估咽鼓管功能障碍(Eustachian tube dysfuction,ETD)患者Valsava动作时的咽鼓管(Eustachian tube,ET)功能。方法 2018年11月~2019年3月期间就诊于首都医科大学附属北京安贞医院的ETD患者15例,无中耳疾病的志愿者15名。使用咽鼓管测压(tubomanometry,TMM),七项咽鼓管功能障碍评分量表(the seven-item Eustachian tube dysfunction questionnaire,ETDQ-7)和咽鼓管评分量表-7(the Eustachian tube score-7,ETS-7)等方法对所有对象咽鼓管功能做初步评价。嘱患者做Valsava动作,行ADCT动态扫描,记录ET开放过程,重建图像。测量ET数值,判断阻塞部位,进行统计学分析。结果 正常对照组可观察到ET全长,ETD组均有不同程度的阻塞。ETD组ET长度和角度显著大于对照组[(44.41±2.21)mm vs(40.60±2.20)mm,P<0.01;(168.73±4.66)mm vs(162.88±5.44)mm,P <0.01],前鼓室部直径显著小于对照组[(3.5±0.8)mm vs(5.3±1.1)mm,P <0.001]。结论 ET长度越长、角度越大,越容易发生ETD。ADCT动态扫描可准确评估ETD患者ET阻塞部位,对咽鼓管球囊扩张术适应证具有指导意义,辐射剂量低,可作为ET常规检查方法。 相似文献
9.
10.
《Survey of ophthalmology》2023,68(5):920-928
There remains limited agreement regarding the efficacy and safety of different antivascular endothelial growth factor (anti-VEGF) agents for the management of polypoidal choroidal vasculopathy (PCV). Our meta-analysis compares different anti-VEGF agents for PCV treatment. Ovid MEDLINE, EMBASE, and Cochrane Library were systematically searched from January 2000 to July 2022. We included articles comparing the efficacy and safety of different anti-VEGF agents, specifically bevacizumab (BEV), ranibizumab (RAN), aflibercept AFL), and brolucizumab (BRO), for patients with PCV. 10,440 studies were identified, 122 underwent full-text review, and seven were included. One study was a randomized trial, and six were observational studies. Ranibizumab and aflibercept were associated with a similar best-corrected visual acuity (BCVA) at the last visit in three observational studies (P = 0.10), similar retinal thickness at the last visit in two observational studies (P = 0.85). One observational study comparing BEV versus RAN found comparable outcomes for final BCVA, retinal thickness, and polyp regression. One randomized trial on BRO versus AFL found comparable outcomes for improvement in BCVA, while anatomical outcomes favored BRO. The available evidence suggests that final BCVA is comparable across different anti-VEGF agents, however, further investigation is warranted due to paucity of evidence. 相似文献